Simultaneous targeting of epidermal growth factor receptor (EGFR) and Met in cancer therapy is less than pre-clinical and medical evaluation. in tumor cell co-cultures and ethnicities with fibroblasts within an MK 3207 HCl additive way weighed against treatment with both solitary real estate agents. Furthermore cell migration assays reveal an increased strength from the MK… Continue reading Simultaneous targeting of epidermal growth factor receptor (EGFR) and Met in